PortalPublikationenOral delta 9-tetrahydrocannabinol improved refractory Gilles...

Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.

Links

  • Alkomiet Hasan
  • Aribert Rothenberger
  • Alexander Münchau
  • Thomas Wobrock
  • Peter Falkai
  • Veit Roessner

Beteiligte Einrichtungen

Abstract

To describe the clinical course of the Delta 9-tetrahydrocannabinol (Delta 9-THC) treatment of a boy with Gilles de la Tourette Syndrome (TS) and comorbid attention-deficit/hyperactivity disorder (ADHD) in relation to Delta 9-THC plasma levels and intracortical inhibition measured by transcranial magnetic stimulation.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer2
ISSN0271-0749
StatusVeröffentlicht - 2010
pubmed 20520294